Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users
Journal of Substance Abuse, Volume 13, No. 1-2, Year 2001
Notification
URL copied to clipboard!
Description
Purpose: To measure prevalence, incidence, and correlates of chlamydia and gonorrhea among injection drug users (IDUs). Methods: Participants (n=2129; 63% male, 52% white, ages 18-30 years) in five US cities were tested for chlamydia and gonorrhea by urine LCR assay and completed a standardized questionnaire about demographics and recent sexual behavior. Logistic regression identified correlates of prevalent infection; incidence rates were calculated from 6-month follow-up data. Results: Chlamydia prevalence was 5.2% and did not differ by gender. Gonorrhea prevalence was 0.2% among men and 2.0% among women, P<.001. Among men, younger age [OR (95% CI): 0.89 (0.83-0.96)], age at sexual debut [0.91 (0.83-0.99)], and African American race [2.92 (1.53-5.59)] were associated with chlamydia. Among women, age at sexual debut [1.16 (1.02-1.31)] and commercial sex [1.96 (1.03-3.74)] were associated with chlamydia, and with gonorrhea [1.27 (1.04-1.56)] and [5.17 (1.66-16.11)], respectively. At 6 months, the cumulative incidence of chlamydia was 1.7% among men and 4.4% among women, P=.03; no men and 1.3% of women tested positive for gonorrhea, P=.01. Implications: Prevalence and correlates of chlamydia and gonorrhea were similar to other samples, suggesting that screening criteria need not be modified for IDU populations. The number of behavioral correlates identified was limited; perhaps unmeasured sexual-network-level factors play a role in determining sexually transmitted disease (STD) prevalence. © 2001 Elsevier Science Inc. All rights reserved.
Authors & Co-Authors
Latka, Mary H.
United States, New York
New York Academy of Medicine
Ahern, Jennifer
United States, New York
New York Academy of Medicine
Garfein, Richard S.
United States, Atlanta
Centers for Disease Control and Prevention
Ouellet, Lawrence J.
United States, Chicago
University of Illinois at Chicago
Kerndt, Peter R.
United States, Los Angeles
University of Southern California
Kim, Yun Jin
United States, New York
Beth Israel Medical Center
Vlahov, David
United States, New York
New York Academy of Medicine
Statistics
Citations: 40
Authors: 7
Affiliations: 6
Identifiers
Doi:
10.1016/S0899-3289(01)00071-2
ISSN:
08993289
Research Areas
Sexual And Reproductive Health
Study Design
Cross Sectional Study
Cohort Study
Participants Gender
Male
Female